Company News
Our new partnership with Kytopen, and the future of lab instrument data
Check out our full press release here for more details. Earlier this week, we announced a new instrument collaboration with Kytopen, a leader in the development and commercialization of non-viral transfection tools for genome engineering. This partnership brings the power of Ganymede’s Lab-as-Code…
Alan Chramiec
Accelerate your analysis with Ganymede’s new data products.
Data is at the heart of every life sciences company. And yet, all too often, it’s treated more as a by-product than an asset. Data management across the industry typically means putting your data anywhere that’s convenient and compliant, without much concern for accessibility and reusability. Meanwh…
Alan Chramiec
Bloomberg TV’s New to The Street Welcomes Our CEO and Co-Founder Nathan Clark
Did you know that today, scientists spend upwards of 20-30% of their work time on data management? Host of Bloomberg TV’s New to The Street Jane King recently sat down with our CEO and co-founder Nathan Clark to discuss how Ganymede solves that problem, accelerating research and providing greater d…
Alan Chramiec
Modern data clouds are vital for biotechs. Unlock their power and don’t get left behind.
Join us on February 23rd 12PM EST for our 1st live webinar. Register here. Cutting-edge mRNA vaccines, advanced cell & gene therapies, and even bringing back extinct animal species: the pace of innovation is accelerating everywhere and every day in the life sciences. Yet, like virtually all other…
Alan Chramiec